Soluble aβ promotes wild-type tau pathology in vivo

Topic: Brain proteins, microglia and lab models

Growing evidence suggests that soluble Aβ species can drive Alzheimer disease (AD) pathogenesis by inducing a cascade of events including tau hyperphosphorylation, proteasome impairment, and synaptic dysfunction. However, these studies have relied largely on in vitro approaches to examine the role of soluble Aβ in AD. In particular, it remains unknown whether soluble Aβ oligomers can facilitate the development of human wild-type tau pathology in vivo. To address this question, we developed a novel transgenic model that expresses low levels of APP with the Arctic familial AD mutation to enhance soluble Aβ oligomer formation in conjunction with wild-type human tau. Using a genetic approach, we show that reduction of β-site APP cleaving enzyme (BACE) in these ArcTau mice decreases soluble Aβ oligomers, rescues cognition, and, more importantly, reduces tau accumulation and phosphorylation. Notably, BACE reduction decreases the postsynaptic mislocalization of tau in ArcTau mice and reduces the association between NMDA receptors and PSD-95. These studies provide critical in vivo evidence for a strong mechanistic link between soluble Aβ, wild-type tau, and synaptic pathology.

@article{chabrier2012-23197725,
  author  = {Chabrier, M. A. and Blurton-Jones, M. and Agazaryan, A. A. and Nerhus, J. L. and Martinez-Coria, H. and LaFerla, F. M.},
  title   = {{Soluble aβ promotes wild-type tau pathology in vivo}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2012},
  doi     = {10.1523/jneurosci.0172-12.2012},
  pmid    = {23197725},
  url     = {https://doi.org/10.1523/jneurosci.0172-12.2012}
}

Key findings

• Growing evidence suggests that soluble Aβ species can drive Alzheimer disease (AD) pathogenesis by inducing a cascade of events including tau hyperphosphorylation, proteasome impairment, and synaptic dysfunction.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1523/jneurosci.0172-12.2012
• PubMed: 23197725
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Related studies in Disease mechanisms

• Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice Molecular neurodegeneration · 2011-06-06 · usefulness score 40/100
• Pin1 has opposite effects on wild-type and P301L tau stability and tauopathy The Journal of clinical investigation · 2008-05-01 · usefulness score 36/100
• High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation Journal of Neuroscience · 2000-06-01 · usefulness score 55/100
• In vivo tau pathology is associated with synaptic loss and altered synaptic function Alzheimer's research & therapy · 2021-02-05 · usefulness score 47/100
• In vivo imaging of tau pathology using multi-parametric quantitative MRI NeuroImage · 2015-02-17 · usefulness score 40/100
• Co-occurrence of multiple pathologies in a case of frontotemporal dementia with TBK1 mutation: first in vivo detection of alpha-synuclein and tau co-pathology Acta Neuropathologica Communications · 2025-07-25 · usefulness score 36/100

Also tagged “phosphorylated”

732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.

• Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease NeuroImage · 2019-07-22 · usefulness score 54/100 · Long-term cohort studies
• Hydration water mobility is enhanced around tau amyloid fibers Proceedings of the National Academy of Sciences of the United States of America · 2015-04-27 · usefulness score 46/100 · Brain scans and imaging
• Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss Scientific reports · 2016-02-18 · usefulness score 40/100 · Disease mechanisms

Similar studies

• APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β 2025 · Biomarkers
• The keystone of Alzheimer pathogenesis might be sought in Aβ physiology 2015 · Disease mechanisms
• Propagation of Tau Pathology in a Model of Early Alzheimer's Disease 2012 · Disease mechanisms
• Amyloid-β and Tau at the Crossroads of Alzheimer's Disease 2019 · Clinical safety
• Tau in Alzheimer disease and related tauopathies 2010 · Lewy body dementia
• Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease 2016 · Disease mechanisms

More on Disease mechanisms

• A review that covers this ground Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature Acta neuropathologica communications · 2021-06-29 · usefulness score 59/100
• Newest in this subject Aβ42 oligomers disrupt calcium homeostasis via Piezo1 and induce neurotoxicity in differentiated SH-SY5Y cells Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation bioRxiv · 2026-10-28 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Disease mechanisms →